09/02/2025 09:15
BearingPoint and ABeam Consulting announce strategic joint venture in the United States to deliver seamless global business transformation

BearingPoint and ABeam Consulting are proud to announce the formation of a new joint venture in the United States, marking a significant milestone in their long-standing strategic alliance. The new entity will operate under the BearingPoint brand and be legally registered as BearingPoint NA LLC. Headquartered in Chicago, its mission is to deliver end-to-end SAP consulting and implementation including SAP Business AI services for clients across the Americas, with a particular focus on the US mar...

08/28/2025 07:00
Europa Worldwide Group Enhances Carbon Management and Reporting With Blue Yonder

The global regulatory landscape, particularly in the U.K. and European Union, acts as a powerful catalyst for change, urging companies to embrace sustainable practices that extend beyond basic compliance. Logistics service providers (LSPs) are witnessing an increased demand from their customers to actively monitor emissions and ensure adherence to both current and forthcoming regulations. That’s why Europa Worldwide Group, a leading LSP with a global presence, has adopted Blue Yonder’s Logistic...

09/19/2025 10:00
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for BILDYOS® (denosumab) injection 60 mg/mL and BILPREVDA® (denosumab) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of the reference products.1,2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919502394/en/ “The EC ...